Literature DB >> 31807380

Hepatitis B and C in Pakistan: A community survey.

Nismat Javed1, Muhammad Hassan Nadeem2, Haider Ghazanfar1.   

Abstract

Objective To assess the efficacy of awareness campaign aimed at Hepatitis B and C in a rural community in Rawalpindi, Pakistan. Methods This is a cross-sectional study conducted on patients from a primary health care facility in Rawalpindi. The duration of the study was three months (April 2019 to June 2019). Patients who were registered at the facility were included after consent had been obtained. The data was collected through a self-constructed questionnaire. The data obtained was analyzed on IBM's statistical package for the social sciences (SPSS) version 21 (IBM, Armonk, NY). Results Out of 35 participants, 16 (46%) were males and 19 (54%) were females. The mean age of the participants was 43.82 ± 19.56 years. The mean number of people in the house was 7.54 ± 3.88. Twenty nine (84%) participants were married while six (16%) participants were not. A majority of the participants had good prior knowledge about Hepatitis B and C. However, a few confusions remained about the mode of transmission, the vector for transmission if any and vaccination protocols. The campaign proved to reinforce many concepts and clear potential confusions of the participants. Conclusions This attempt at improving awareness proved to be fruitful. There is a dire need to ensure that multiple activities are organized so that the burden of the disease may be reduced. There will be a strong network of communication for flow of information if the activities occur regularly and in a focused manner.
Copyright © 2019, Javed et al.

Entities:  

Keywords:  awareness; hbv; hcv; pakistan

Year:  2019        PMID: 31807380      PMCID: PMC6876910          DOI: 10.7759/cureus.5992

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  17 in total

Review 1.  What Is Needed to Eliminate Hepatitis B Virus and Hepatitis C Virus as Global Health Threats.

Authors:  John W Ward; Alan R Hinman
Journal:  Gastroenterology       Date:  2018-11-02       Impact factor: 22.682

2.  Prevalence of hepatitis B virus in the Kurram Agency, Pakistan: A 5-year observational study in a war-affected region.

Authors:  Sabir Hussain; Zameer Ali
Journal:  J Clin Virol       Date:  2016-06-23       Impact factor: 3.168

Review 3.  Diagnosis and management of autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  Clin Liver Dis       Date:  2014-11-21       Impact factor: 6.126

4.  Clinical features of autoimmune hepatitis and comparison of two diagnostic criteria in Korea: a nationwide, multicenter study.

Authors:  Bo Hyun Kim; Yoon Jun Kim; Sook-Hyang Jeong; Won Young Tak; Sang Hoon Ahn; Youn Jae Lee; Eun Uk Jung; Jung Il Lee; Jong Eun Yeon; Jae Seok Hwang; Soon Ho Um; Yeon Seok Seo; Young Seok Kim; Byung Cheol Song; Ju Hyun Kim; Young Kul Jung; Choong Kee Park; Kyung-Ah Kim; Hyun Ju Min; Eun Young Cho; Eom Seok Lee; So Young Kwon; Hee Bok Chae; Dong Joon Kim; Su Rin Shin
Journal:  J Gastroenterol Hepatol       Date:  2013-01       Impact factor: 4.029

Review 5.  Hepatitis B virus burden in developing countries.

Authors:  Rosa Zampino; Adriana Boemio; Caterina Sagnelli; Loredana Alessio; Luigi Elio Adinolfi; Evangelista Sagnelli; Nicola Coppola
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

6.  Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis.

Authors:  Thawab Al-Chalabi; James A Underhill; Bernard C Portmann; Ian G McFarlane; Michael A Heneghan
Journal:  J Hepatol       Date:  2007-10-22       Impact factor: 25.083

7.  Relation between autoimmune liver diseases and viral hepatitis: clinical and serological characteristics in 859 patients.

Authors:  A W Lohse; G Gerken; H Mohr; H F Löhr; U Treichel; H P Dienes; K H Meyer zum Büschenfelde
Journal:  Z Gastroenterol       Date:  1995-09       Impact factor: 2.000

Review 8.  Prospects for prophylactic hepatitis C vaccines based on virus-like particles.

Authors:  Elodie Beaumont; Philippe Roingeard
Journal:  Hum Vaccin Immunother       Date:  2013-02-13       Impact factor: 3.452

Review 9.  Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.

Authors:  Ralf Bartenschlager; Thomas F Baumert; Jens Bukh; Michael Houghton; Stanley M Lemon; Brett D Lindenbach; Volker Lohmann; Darius Moradpour; Thomas Pietschmann; Charles M Rice; Robert Thimme; Takaji Wakita
Journal:  Virus Res       Date:  2018-03-02       Impact factor: 3.303

10.  More than a virus: a qualitative study of the social implications of hepatitis B infection in China.

Authors:  J Wallace; M Pitts; C Liu; V Lin; B Hajarizadeh; J Richmond; S Locarnini
Journal:  Int J Equity Health       Date:  2017-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.